The Long-Lasting Protective Effect of HGF in Cardiomyoblasts Exposed to Doxorubicin Requires a Positive Feed-Forward Loop Mediated by Erk1,2-Timp1-Stat3
Previous studies showed that the hepatocyte growth factor (HGF)–Met receptor axis plays long-lasting cardioprotection against doxorubicin anti-cancer therapy. Here, we explored the mechanism(s) underlying the HGF protective effect. DNA damage was monitored by histone H2AX phosphorylation and apoptos...
Main Authors: | Simona Gallo, Martina Spilinga, Elena Casanova, Alessandro Bonzano, Carla Boccaccio, Paolo Maria Comoglio, Tiziana Crepaldi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/15/5258 |
Similar Items
-
Role and Therapeutic Targeting of the HGF/MET Pathway in Glioblastoma
by: Nichola Cruickshanks, et al.
Published: (2017-07-01) -
HGF and MET: From Brain Development to Neurological Disorders
by: Claudia Desole, et al.
Published: (2021-06-01) -
The role of HGF/c-MET signaling pathway in lymphoma
by: Bao Quoc Lam, et al.
Published: (2016-12-01) -
ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy
by: Simona Gallo, et al.
Published: (2019-05-01) -
MACC1 Contributes to the Development of Osteosarcoma Through Regulation of the HGF/c-Met Pathway and Microtubule Stability
by: Jia Wen, et al.
Published: (2020-12-01)